Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report)’s share price was down 24.6% during trading on Friday . The stock traded as low as $4.07 and last traded at $4.07. Approximately 325 shares traded hands during mid-day trading, a decline of 48% from the average daily volume of 629 shares. The stock had previously closed at $5.40.
Sigyn Therapeutics Price Performance
The business has a 50 day moving average price of $5.41 and a two-hundred day moving average price of $5.42.
About Sigyn Therapeutics
Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.
Recommended Stories
- Five stocks we like better than Sigyn Therapeutics
- Conference Calls and Individual Investors
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- What is a Stock Market Index and How Do You Use Them?
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- How Technical Indicators Can Help You Find Oversold StocksÂ
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
